ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Properties of flavonoids in the treatment of bladder cancer (Review)

Lv, Yue; Liu, Zhonghao; Jia, Haixing; Xiu, Youcheng; Liu, Zan; Deng, Leihong南昌大学; 哈尔滨医科大学; 1
Experimental and Therapeutic Medicine2022-11DOI: 10.3892/etm.2022.11612
5被引8阅读
引用收藏
分享

摘要

Given its high recurrence and rapid progress, bladder cancer (BLCA) treatment has become a major problem for clinicians. BLCA is difficult to control even with surgical resection and extensive use of chemotherapeutic drugs. The non-toxicity and ease of accessibility of natural compounds have attracted much attention in recent years. Flavonoids serve an essential role given their antioxidant, antibacterial, anticancer and cardiovascular properties. They are mainly divided into several subclasses; flavones, flavanones, flavonols, flavanols, anthocyanins isoflavones and chalcones. Over the years, the role of flavonoids in BLCA has been extensively studied. The present review provided a comprehensive overview of the classification of flavonoids and substantiate the role of epithelial-mesenchymal transition, cancer stem cells, angiogenesis, epigenetic regulation and programmed cell death in BLCA. The present review emphasized that flavonoids for BLCA treatment are worthy of further study and anti-BLCA drugs have huge prospects for clinical use.

学科与关键词

关键词
bladder cancerflavonoidsapoptosiscell cycle
相关
加载中…
  • Natural Phytochemicals in Bladder Cancer Prevention and Therapy
    Xia, Yong*; Chen, Ruijiao; Lu, Guangzhen; Li, Changlin; Lian, Sen; Kang, Taek-Won; Jung, Young Do*Frontiers in Oncology, 2021, 11: 652033.被引 16
  • Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment
    Zhou, Huanhuan; Wang, Ping; Qin, Xian; Zhang, Xing*; Lai, Keng Po*; Chen, Jian*Food & Function, 2023, 14(12): 5787-5804.
  • The protoapigenone analog WYC0209 targets CD133+cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy
    Yeh, Bi-Wen; Yu, Liang-En; Li, Ching-Chia; Yang, Juan-Cheng; Li, Wei-Ming; Wu, Yang-Chang; Wei, Yu-Ching; Lee, Hsueh-Te; Kung, Mei-Lang; Wu, Wen-JengToxicology and Applied Pharmacology, 2020, 402: 115129.
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental and Therapeutic Medicine
发表日期
2022-11
卷期
第 24 卷, 第 5 期
页码
676
DOI
10.3892/etm.2022.11612
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
[186]

作者

  • L

    Lv, Yue (第一作者)

    1 · harbin med univ

  • L

    Liu, Zhonghao

查看全部 6 位作者收起作者
  • J

    Jia, Haixing

    1 · harbin med univ

  • X

    Xiu, Youcheng

    1 · harbin med univ

  • L

    Liu, Zan

  • D

    Deng, Leihong

    1 · nanchang univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417